SCHEMBL19533569

SCHEMBL19533569

CC(=O)c1[nH]nc(-c2ccc(Oc3ccccn3)cc2)c1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ IP6K1 Q92551 1/20 0.39
▸ IP6K3 Q96PC2 1/20 0.39
▸ IP6K2 Q9UHH9 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SCN9A Q15858 1/20 0.37
▸ ACACB O00763 1/20 0.37
▸ ACACA Q13085 1/20 0.37
▸ ADAMTS4 O75173 1/20 0.37
▸ RAB9A P51151 1/20 0.36
▸ PTGS2 P35354 2/20 0.35
▸ TNK2 Q07912 1/20 0.35
▸ LTA4H P09960 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ TTK P33981 1/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ SCN7A Q01118 2/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ PRMT5 O14744 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19544677 0.86 PTGS2 (0.48) DHODHALDH1A1MAPTSCN9APTGS2
SCHEMBL19533553 0.85 ERBB2 (0.41) DHODHALDH1A1MAPTSCN9AACACB
SCHEMBL19624943 0.77 ALDH1A1 (0.53) DHODHALDH1A1MAPTSCN9ARAB9A
SCHEMBL23294370 0.74 HAO1 (0.49) DHODHIP6K1IP6K3IP6K2SCN9A
SCHEMBL29852005 0.74 HAO1 (0.49) DHODHIP6K1IP6K3IP6K2SCN9A
SCHEMBL19533570 0.74 ALPL (0.49) DHODHALDH1A1MAPTRAB9A
SCHEMBL19533664 0.74 FFAR1 (0.39) ALDH1A1MAPTACACBRAB9ATTK
SCHEMBL5598667 0.72 RAB9A (0.58) ALDH1A1IP6K1IP6K3IP6K2MAPT
SCHEMBL19544658 0.71 SCN9A (0.54) ALDH1A1MAPTSCN9ARAB9APTGS2
SCHEMBL19533659 0.70 HPGDS (0.48) ALDH1A1MAPTSCN9AACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170313683-A1 BTK INHIBITOR HUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECHNOLOGICAL INSTITUTE, INC. (CN) 2017-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170313683-A1 BTK INHIBITOR BTK, SYK, LYN DHODH 1587/4885ALDH1A1 4122/4885IP6K1 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback